ClinicalTrials.Veeva

Menu

Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 2

Conditions

Cocaine-Related Disorders
Alcohol-Related Disorders

Treatments

Drug: Naltrexone

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000307
NIDA-09262-4
P50-09262-4

Details and patient eligibility

About

The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.

Sex

All

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems